Delivery of Immobilized IFN-γ With PCN-333 and Its Effect on Human Mesenchymal Stem Cells
dc.contributor.author | Phipps, Josh | |
dc.contributor.author | Haseli, Mahsa | |
dc.contributor.author | Pinzon-Herrera, Luis | |
dc.contributor.author | Wilson, Ben | |
dc.contributor.author | Corbitt, Joshua | |
dc.contributor.author | Servoss, Shannon | |
dc.contributor.author | Almodovar, Jorge | |
dc.date.accessioned | 2024-03-26T17:35:46Z | |
dc.date.available | 2024-03-26T17:35:46Z | |
dc.date.issued | 2023-01-04 | |
dc.description.abstract | Interferon-gamma (IFN-γ) plays a vital role in modulating the immunosuppressive properties of human mesenchymal stem/stromal cells (hMSCs) used in cell therapies. However, IFN-γ suffers from low bioavailability and degrades in media, creating a challenge when using IFN-γ during the manufacturing of hMSCs. Metal–organic frameworks (MOFs), with their porous interiors, biocompatibility, high loading capacity, and ability to be functionalized for targeting, have become an increasingly suitable platform for protein delivery. In this work, we synthesize the MOF PCN-333(Fe) and show that it can be utilized to immobilize and deliver IFN-γ to the local extracellular environment of hMSCs. In doing so, the cells proliferate and differentiate appropriately with no observed side effects. We demonstrate that PCN-333(Fe) MOFs containing IFN-γ are not cytotoxic to hMSCs, can promote the expression of proteins that play a role in immune response, and are capable of inducing indoleamine 2,3-dioxygenase (IDO) production similar to that of soluble IFN-γ at lower concentrations. Overall, using MOFs to deliver IFN-γ may be leveraged in the future in the manufacturing of therapeutically relevant hMSCs. | |
dc.description.sponsorship | This work was financially supported in part by the National Science Foundation under grant no. 2051582 and by the University of Arkansas Cell and Molecular Biology Graduate Program by providing J.P. with a scholarship.The authors thank the Arkansas Nano & Biomaterials Characterization Facility for their assistance with SEM. The authors thank the University of Arkansas Chemistry Department for access to the XRD. | |
dc.description.uri | https://pubs.acs.org/doi/10.1021/acsbiomaterials.2c01038 | |
dc.format.extent | 11 pages | |
dc.genre | journal articles | |
dc.genre | postprints | |
dc.identifier | doi:10.13016/m2quyx-p8ak | |
dc.identifier.citation | Phipps, Josh, Mahsa Haseli, Luis Pinzon-Herrera, Ben Wilson, Joshua Corbitt, Shannon Servoss, and Jorge Almodovar. “Delivery of Immobilized IFN-γ With PCN-333 and Its Effect on Human Mesenchymal Stem Cells.” ACS Biomaterials Science & Engineering 9, no. 2 (February 13, 2023): 671–79. https://doi.org/10.1021/acsbiomaterials.2c01038. | |
dc.identifier.uri | https://doi.org/10.1021/acsbiomaterials.2c01038 | |
dc.identifier.uri | http://hdl.handle.net/11603/32606 | |
dc.publisher | ACS | |
dc.relation.isAvailableAt | The University of Maryland, Baltimore County (UMBC) | |
dc.relation.ispartof | UMBC Chemical, Biochemical & Environmental Engineering Department Collection | |
dc.rights | This document is the Accepted Manuscript version of a Published Work that appeared in final form in ACS Biomaterials Science & Engineering, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see https://doi.org/10.1021/acsbiomaterials.2c01038. | |
dc.title | Delivery of Immobilized IFN-γ With PCN-333 and Its Effect on Human Mesenchymal Stem Cells | |
dc.type | Text | |
dcterms.creator | https://orcid.org/0000-0002-1151-3878 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- IFN manuscript (Revised and clean) TOC Delivery of Immobilized IFN.pdf
- Size:
- 2.41 MB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 2.56 KB
- Format:
- Item-specific license agreed upon to submission
- Description: